Prosthetic heart valves and the COVID-19 pandemic era: What should we be concerned about?
Negar OmidiSeyed Khalil ForouzanniaHamidreza PoorhosseiniSeyed Hossein Ahmadi TaftiShahrzad SalehbeigiMasoumeh Lotfi TokaldaniPublished in: Journal of cardiac surgery (2020)
Antiviral therapy in patients with COVID-19 with prosthetic heart valves might be an issue responsible for an uncontrolled INR. Liver injury may happen in a minority of patients. Bridging in these patients during the antiviral treatment might be required and because of significant INR fluctuations, it might be safer to prescribe antiviral treatment in an inpatient setting.
Keyphrases
- end stage renal disease
- liver injury
- ejection fraction
- newly diagnosed
- drug induced
- heart failure
- peritoneal dialysis
- prognostic factors
- palliative care
- aortic valve
- mental health
- aortic valve replacement
- combination therapy
- transcatheter aortic valve implantation
- smoking cessation
- transcatheter aortic valve replacement